Wire Stories
-
26.3KUbiquitome gets FDA authorization with Yale SARS-CoV-2 self-collection tests
NIH RADx winner�s next gen Liberty16 Pro gets EUA AUCKLAND, New Zealand–(BUSINESS WIRE)–#COVIDCATCHER–Ubiquitome�s next generation real time PCR device system, the Liberty16...
-
27.9KKyocera Plans New Manufacturing Plant in Japan�s Nagasaki Prefecture by 2026
Company envisions up to 1,000 jobs in Isahaya City as other sites near full capacity KYOTO, JAPAN–(BUSINESS WIRE)–Kyocera Corporation (President: Hideo Tanimoto;...
-
25.3KDr. Reddy�s Successfully Completes Phase 1 Study of DRL_TC, a Proposed Biosimilar of Tocilizumab
Tocilizumab is an important anti-rheumatic agent used in the treatment of adult patients with moderate to severe active rheumatoid arthritis who have...
-
26.6KIntroducing THE BRIJ – A World of Arts and Culture
Serendipity Arts announces THE BRIJ, a futuristic arts and culture centre in the National Capital Region that will host multiple creative projects...
-
25.8KMovers Buddy Reports Affordable Suburbs To Move To If You Want To Save On Rent In Melbourne And Sydney
MELBOURNE, Australia–(BUSINESS WIRE)–As rents continue to soar, Australian families are struggling more than ever before to find affordable housing. When asked about...
-
28.2KDongying seeks trade opportunities in overseas markets
DONGYING, China–(BUSINESS WIRE)–Dongying, a city in East China�s Shandong province, has been helping local enterprises expand in international markets as part of...
-
29.0KA Third of Businesses Predict the Current Inflationary Environment to Last More Than Two Years – Taulia
SAN FRANCISCO–(BUSINESS WIRE)–A third of global businesses predict the current inflationary environment to continue for more than two years, according to new...
-
33.6KENHERTU� Recommended for Approval in the EU by CHMP for Patients with HER2 Low Metastatic Breast Cancer
Daiichi Sankyo and AstraZeneca�s ENHERTU is the first HER2 directed therapy to demonstrate a significant survival benefit versus chemotherapy in this patient...
-
39.5KENHERTU� Approved in the EU for Patients with Previously Treated HER2 Positive Advanced Gastric Cancer
First HER2 directed medicine to be approved for gastric cancer in the EU in more than a decade Based on DESTINY-Gastric02 and...
-
28.1KMitsubishi Electric to Delist Shares on London Stock Exchange
TOKYO–(BUSINESS WIRE)–Mitsubishi Electric Corporation (TOKYO:6503) announced today that it has decided to apply for the delisting of its shares of common stock...
To Top